Institutionalizing M&A Excellence In Health Care
Executive Summary
M&A deals, particularly smaller ones, are the lifeblood of the health care industry. Despite evident success in dealmaking, McKinsey says that pharma and medtech firms can benefit by bringing better consistency, transparency and accountability to their M&A programs.